Ann:COVIRIX Medical and Numolux Group Media Release (Price Sensitive), page-2

23 August 2023
NSX Announcements
Re: COVIRIX Medical and Numolux Group Media Release
Please find attached media release distributed globally by the Numolux Group of South Africa.
The Numolux Group launched the BRICS Health and Pharmaceutical Association of Africa in
May 2023.
BRICS is a significant political alliance of Brazil, Russia, India, China, and South Africa.
Collectively, BRICS accounts for over 31% of global GDP and over 40% of global population.
40 additional countries have applied formally to join BRICS or have expressed the intention to
join. The 15th BRICS Summit is being hosted by South Africa between 22 and 24 August 2023
in Johannesburg.
Numolux Group and COVIRIX Medical Pty Ltd have entered into a strategic partnership:
that will focus on establishing an inhaled antiviral drug development platform by
repurposing, starting with South Africa for the African continent, then extending to the
entire BRICS + Alliance for treatment of diseases, starting with viral respiratory
intra-nasal inhalational delivery routes.
the parties will co-operate with each other in the areas of pre-clinical and clinical
research, registration, marketing, and distribution of antiviral products in South African
and other African markets.
COVIRIX Medical is the first Australian pharmaceutical company to position itself in
the BRICS + Alliance, leveraging on the strong business relationships of the Numolux
Group within South Africa, a key member of the BRICS + Alliance, and the leadership
of South Africa within the African continent, a market with a population of over 1.4
billion people.
Go Green Holdings Ltd is a significant shareholder of COVIRIX Medical with a 24%
shareholding interest.
NSX listed GoConnect Ltd (GO8) holds a 43% shareholding interest in Go Green Holdings